Cross-trial Analysis of Immunologic and Clinical Data Resulting From Phase I and II Trials of MVA-5T4 (TroVax) in Colorectal, Renal, and Prostate Cancer Patients

2010 ◽  
Vol 33 (9) ◽  
pp. 999-1005 ◽  
Author(s):  
Richard Harrop ◽  
William Shingler ◽  
Michelle Kelleher ◽  
Jackie de Belin ◽  
Peter Treasure
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Cancer Patients ◽  
Clinical Data ◽  
Trial Analysis ◽  
Phase I And Ii

A phase I/II study of acute and late physician assessed and patient-reported morbidity following whole pelvic radiation in high-risk prostate cancer patients

2021 ◽  
pp. 1-6
Author(s):  
Stine E. Petersen ◽  
Lise B. Thorsen ◽  
Steinbjørn Hansen ◽  
Peter M. Petersen ◽  
Henriette Lindberg ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
High Risk ◽  
Phase I ◽  
Cancer Patients ◽  
Pelvic Radiation ◽  
High Risk Prostate Cancer ◽  
Patient Reported ◽  
Risk Prostate Cancer

The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study

The Prostate ◽  
2011 ◽  
Vol 71 (13) ◽  
pp. 1455-1465 ◽  
Author(s):  
Jayaprakash Karkera ◽  
Hannes Steiner ◽  
Weimin Li ◽  
Viktor Skradski ◽  
Patrizia L. Moser ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Cancer Patients ◽  
Interleukin 6 ◽  
Phase I Study

scholarly journals Investigation of risk factors for prostate cancer patients with bone metastasis based on clinical data

2010 ◽  
Vol 1 (4) ◽  
pp. 635-639 ◽  
Author(s):  
YOSHIAKI YAMADA ◽  
KATSUYA NARUSE ◽  
KOGENTA NAKAMURA ◽  
TOMOHIRO TAKI ◽  
MOTOI TOBIUME ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Risk Factors ◽  
Bone Metastasis ◽  
Cancer Patients ◽  
Clinical Data

Results from a first in man Phase I/II adjuvant Dendritic Cell Vaccine study in high risk prostate cancer patients following radical surgery

Cytotherapy ◽  
2017 ◽  
Vol 19 (5) ◽  
pp. S15 ◽  
Author(s):  
A.A. Tryggestad ◽  
I. Bigalke ◽  
K. Axcrona ◽  
E. Inderberg ◽  
G. Skorstad ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Dendritic Cell ◽  
High Risk ◽  
Phase I ◽  
Cancer Patients ◽  
Radical Surgery ◽  
Dendritic Cell Vaccine ◽  
Cell Vaccine ◽  
High Risk Prostate Cancer ◽  
Risk Prostate Cancer
Sign in / Sign up

Export Citation Format

Share Document